• 1. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives

Introduction to (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol and Its Significance in Modern Chemical Biology

(1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol, with the CAS number 1202070-41-4, is a compound of significant interest in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique structural and functional properties, has garnered attention for its potential applications in drug discovery and development. The presence of a 5-fluoropyridin-2-yl moiety in its structure imparts distinct chemical and biological characteristics, making it a valuable scaffold for designing novel therapeutic agents.

The compound's stereochemistry, specifically the (1R) configuration, plays a crucial role in determining its biological activity. Chiral drugs often exhibit different pharmacological profiles depending on their stereochemical orientation, and (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol is no exception. This specificity is particularly important in the development of targeted therapies, where precise molecular interactions are essential for efficacy and safety.

In recent years, there has been a growing interest in fluorinated pyridine derivatives due to their enhanced metabolic stability and improved binding affinity to biological targets. The 5-fluoropyridin-2-yl group in (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol contributes to these advantageous properties, making it an attractive component in the design of small-molecule drugs. Studies have shown that fluorine atoms can significantly influence the pharmacokinetic behavior of molecules, often leading to better drug performance.

One of the most compelling aspects of (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol is its potential as a building block for more complex pharmacophores. Researchers have leveraged its structural features to develop novel compounds with enhanced biological activity. For instance, recent studies have explored its use in the synthesis of kinase inhibitors, where the fluoropyridine moiety serves as a key pharmacophore for target binding. These inhibitors have shown promise in preclinical trials for the treatment of various cancers and inflammatory diseases.

The compound's utility extends beyond kinase inhibition. Its unique structure also makes it a valuable candidate for developing antiviral and antibacterial agents. The fluorine atom's ability to enhance binding interactions with viral proteases and bacterial enzymes has been exploited to create new classes of therapeutic molecules. Furthermore, the chiral center in (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol allows for the synthesis of enantiomerically pure compounds, which are often required for optimal pharmacological activity.

The synthesis of (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol presents unique challenges due to its complex stereochemistry and the need for high enantiomeric purity. Advanced synthetic methodologies, such as asymmetric hydrogenation and chiral resolution techniques, have been employed to achieve this goal. These methods not only ensure high yield but also maintain the integrity of the compound's stereochemical configuration, which is critical for its biological activity.

Recent advancements in computational chemistry have further enhanced the understanding of (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol's properties. Molecular modeling studies have provided insights into how this compound interacts with biological targets at the atomic level. These insights have guided the optimization of its structure to improve binding affinity and reduce potential side effects. Such computational approaches are becoming increasingly integral in drug discovery, allowing researchers to predict and manipulate molecular interactions with unprecedented precision.

The potential applications of (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol are vast and span multiple therapeutic areas. Its role in developing targeted therapies underscores its importance in modern medicine. As research continues to uncover new biological functions and mechanisms, this compound is likely to play an even greater role in addressing unmet medical needs.

In conclusion, (1R)-1-(5-fluoropyridin-2-yl)ethan-1-ol is a remarkable molecule with significant implications for chemical biology and pharmaceutical science. Its unique structural features, combined with its potential as a drug scaffold, make it a cornerstone in the development of innovative therapeutics. As our understanding of molecular interactions continues to evolve, compounds like this will undoubtedly shape the future of medicine.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)